Z-VAD-FMK
To Order Contact us: stephen@expresspharmapulse.com
Z-VAD-FMK |
A1902-10 |
ApexBio |
10 mg |
EUR 408 |
Description: Z-VAD-FMK, an inhibitor of ICE-like proteases, inhibits apoptosis in THP.1 cells induced by diverse stimuli1 and Fas antigen-induced apoptosis in Jurkat T-cells2. |
Z-VAD-FMK |
A1902-25 |
ApexBio |
25 mg |
EUR 616.8 |
Description: Z-VAD-FMK, an inhibitor of ICE-like proteases, inhibits apoptosis in THP.1 cells induced by diverse stimuli1 and Fas antigen-induced apoptosis in Jurkat T-cells2. |
Z-VAD-FMK |
A1902-5 |
ApexBio |
5 mg |
EUR 268.8 |
Description: Z-VAD-FMK, an inhibitor of ICE-like proteases, inhibits apoptosis in THP.1 cells induced by diverse stimuli1 and Fas antigen-induced apoptosis in Jurkat T-cells2. |
Z-VAD-FMK |
A1902-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 268.8 |
Description: Z-VAD-FMK, an inhibitor of ICE-like proteases, inhibits apoptosis in THP.1 cells induced by diverse stimuli1 and Fas antigen-induced apoptosis in Jurkat T-cells2. |
Caspase-Family Inhibitor Z-VAD-FMK |
1010-100 |
Biovision |
|
EUR 235.2 |
Caspase-Family Inhibitor Z-VAD-FMK |
1010-20C |
Biovision |
|
EUR 235.2 |
SRB-VAD-FMK [Sulforhodamine B-VAD-FMK] |
13472 |
AAT Bioquest |
25 Tests |
EUR 158.4 |
|
SRB-VAD-FMK [Sulforhodamine B-VAD-FMK] |
13482 |
AAT Bioquest |
100 Tests |
EUR 211 |
Z-VAD-FMK (Pan-specific caspase inhibitor) |
SIH-557-1MG |
Stressmarq |
1 mg |
EUR 231.6 |
Description: The substance Z-VAD-FMK is a pan-specific caspase inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is lyophilized solid or wax which is May be dissolved in DMSO (10 mg/ml). |
Z-YVAD-FMK |
A8955-1 |
ApexBio |
1 mg |
EUR 282 |
Description: Z-YVAD-FMK is a potent cell-permeable and irreversible inhibitor of caspase-1.In Caco-2 cells, Z-YVAD-FMK significantly decreased the growth inhibition induced by butyrate. |
Z-YVAD-FMK |
A8955-5 |
ApexBio |
5 mg |
EUR 616.8 |
Description: Z-YVAD-FMK is a potent cell-permeable and irreversible inhibitor of caspase-1.In Caco-2 cells, Z-YVAD-FMK significantly decreased the growth inhibition induced by butyrate. |
Z-YVAD-FMK |
A8955-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 1326 |
Description: Z-YVAD-FMK is a potent cell-permeable and irreversible inhibitor of caspase-1.In Caco-2 cells, Z-YVAD-FMK significantly decreased the growth inhibition induced by butyrate. |
Z-FA-FMK |
A8170-1 |
ApexBio |
1 mg |
EUR 142.8 |
Description: Z-FA-FMK is a control peptidic fluoromethylketone (boc-Thr-CH2F), and inhibitor to calpain (Ac-Leu-Leu-norleucinal), cathepsin B (Z-Phe-Ala-CH2F), and CPP32-like proteases (Z-DEVD-CH2F) [1]. |
Z-FA-FMK |
A8170-10 |
ApexBio |
10 mg |
EUR 560.4 |
Description: Z-FA-FMK is a control peptidic fluoromethylketone (boc-Thr-CH2F), and inhibitor to calpain (Ac-Leu-Leu-norleucinal), cathepsin B (Z-Phe-Ala-CH2F), and CPP32-like proteases (Z-DEVD-CH2F) [1]. |
Z-FA-FMK |
A8170-25 |
ApexBio |
25 mg |
EUR 616.8 |
Description: Z-FA-FMK is a control peptidic fluoromethylketone (boc-Thr-CH2F), and inhibitor to calpain (Ac-Leu-Leu-norleucinal), cathepsin B (Z-Phe-Ala-CH2F), and CPP32-like proteases (Z-DEVD-CH2F) [1]. |
Z-FA-FMK |
A8170-5 |
ApexBio |
5 mg |
EUR 338.4 |
Description: Z-FA-FMK is a control peptidic fluoromethylketone (boc-Thr-CH2F), and inhibitor to calpain (Ac-Leu-Leu-norleucinal), cathepsin B (Z-Phe-Ala-CH2F), and CPP32-like proteases (Z-DEVD-CH2F) [1]. |
Z-FA-FMK |
A8170-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 408 |
Description: Z-FA-FMK is a control peptidic fluoromethylketone (boc-Thr-CH2F), and inhibitor to calpain (Ac-Leu-Leu-norleucinal), cathepsin B (Z-Phe-Ala-CH2F), and CPP32-like proteases (Z-DEVD-CH2F) [1]. |
Z-FA-FMK |
A8170-S |
ApexBio |
Evaluation Sample |
EUR 97.2 |
Description: Z-FA-FMK is a control peptidic fluoromethylketone (boc-Thr-CH2F), and inhibitor to calpain (Ac-Leu-Leu-norleucinal), cathepsin B (Z-Phe-Ala-CH2F), and CPP32-like proteases (Z-DEVD-CH2F) [1]. |
Z-DEVD-FMK |
A1920-1 |
ApexBio |
1 mg |
EUR 135.6 |
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death. |
Z-DEVD-FMK |
A1920-10 |
ApexBio |
10 mg |
EUR 408 |
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death. |
Z-DEVD-FMK |
A1920-25 |
ApexBio |
25 mg |
EUR 616.8 |
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death. |
Z-DEVD-FMK |
A1920-5 |
ApexBio |
5 mg |
EUR 268.8 |
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death. |
Z-DEVD-FMK |
A1920-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 351.6 |
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death. |
Z-DEVD-FMK |
A1920-S |
ApexBio |
Evaluation Sample |
EUR 97.2 |
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death. |
Z-DQMD-FMK |
A1921-1 |
ApexBio |
1 mg |
EUR 135.6 |
Description: Inhibition of caspase-3 processing by Z-DQMD-FMK (Z-Asp(OMe)-Gln-Met-Asp(OMe)-fluoromethylketone) did not restore cell number in the zinc-deficient group, but resulted in processing of full-length PKC-? to a 56-kDa fragment1. |
Z-DQMD-FMK |
A1921-10 |
ApexBio |
10 mg |
EUR 408 |
Description: Inhibition of caspase-3 processing by Z-DQMD-FMK (Z-Asp(OMe)-Gln-Met-Asp(OMe)-fluoromethylketone) did not restore cell number in the zinc-deficient group, but resulted in processing of full-length PKC-? to a 56-kDa fragment1. |
Z-DQMD-FMK |
A1921-25 |
ApexBio |
25 mg |
EUR 616.8 |
Description: Inhibition of caspase-3 processing by Z-DQMD-FMK (Z-Asp(OMe)-Gln-Met-Asp(OMe)-fluoromethylketone) did not restore cell number in the zinc-deficient group, but resulted in processing of full-length PKC-? to a 56-kDa fragment1. |
Z-DQMD-FMK |
A1921-5 |
ApexBio |
5 mg |
EUR 268.8 |
Description: Inhibition of caspase-3 processing by Z-DQMD-FMK (Z-Asp(OMe)-Gln-Met-Asp(OMe)-fluoromethylketone) did not restore cell number in the zinc-deficient group, but resulted in processing of full-length PKC-? to a 56-kDa fragment1. |
Z-DQMD-FMK |
A1921-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 518.4 |
Description: Inhibition of caspase-3 processing by Z-DQMD-FMK (Z-Asp(OMe)-Gln-Met-Asp(OMe)-fluoromethylketone) did not restore cell number in the zinc-deficient group, but resulted in processing of full-length PKC-? to a 56-kDa fragment1. |
Z-DQMD-FMK |
A1921-S |
ApexBio |
Evaluation Sample |
EUR 97.2 |
Description: Inhibition of caspase-3 processing by Z-DQMD-FMK (Z-Asp(OMe)-Gln-Met-Asp(OMe)-fluoromethylketone) did not restore cell number in the zinc-deficient group, but resulted in processing of full-length PKC-? to a 56-kDa fragment1. |
Z-VDVAD-FMK |
A1922-1 |
ApexBio |
1 mg |
EUR 212.4 |
Description: Jurkat T-lymphocytes treated with an irreversible caspase-2 inhibitor, benzyloxycarbonyl-Val-Asp(OMe)-Val-Ala-Asp(OMe)-fluoromethyl ketone (Z-VDVAD-FMK), or stably transfected with pro-caspase-2 antisense (Casp-2/AS) are refractory to cytochrome c release stimulated by etoposide1. |
Z-VDVAD-FMK |
A1922-10 |
ApexBio |
10 mg |
EUR 756 |
Description: Jurkat T-lymphocytes treated with an irreversible caspase-2 inhibitor, benzyloxycarbonyl-Val-Asp(OMe)-Val-Ala-Asp(OMe)-fluoromethyl ketone (Z-VDVAD-FMK), or stably transfected with pro-caspase-2 antisense (Casp-2/AS) are refractory to cytochrome c release stimulated by etoposide1. |
Z-VDVAD-FMK |
A1922-25 |
ApexBio |
25 mg |
EUR 1173.6 |
Description: Jurkat T-lymphocytes treated with an irreversible caspase-2 inhibitor, benzyloxycarbonyl-Val-Asp(OMe)-Val-Ala-Asp(OMe)-fluoromethyl ketone (Z-VDVAD-FMK), or stably transfected with pro-caspase-2 antisense (Casp-2/AS) are refractory to cytochrome c release stimulated by etoposide1. |
Z-VDVAD-FMK |
A1922-5 |
ApexBio |
5 mg |
EUR 477.6 |
Description: Jurkat T-lymphocytes treated with an irreversible caspase-2 inhibitor, benzyloxycarbonyl-Val-Asp(OMe)-Val-Ala-Asp(OMe)-fluoromethyl ketone (Z-VDVAD-FMK), or stably transfected with pro-caspase-2 antisense (Casp-2/AS) are refractory to cytochrome c release stimulated by etoposide1. |
Z-VDVAD-FMK |
A1922-S |
ApexBio |
Evaluation Sample |
EUR 97.2 |
Description: Jurkat T-lymphocytes treated with an irreversible caspase-2 inhibitor, benzyloxycarbonyl-Val-Asp(OMe)-Val-Ala-Asp(OMe)-fluoromethyl ketone (Z-VDVAD-FMK), or stably transfected with pro-caspase-2 antisense (Casp-2/AS) are refractory to cytochrome c release stimulated by etoposide1. |
Z-VEID-FMK |
A1923-1 |
ApexBio |
1 mg |
EUR 212.4 |
Description: When compared to other caspase inhibitors, Z-DRHD-FMK inhibited caspase 6 activity more effectively than the general caspase inhibitor Z-Val-Ala-Asp (OMe)-fluoromethy ketone (Z-VAD-FMK) or the caspase 6 inhibitor Z-Val-Glu(Ome)-Ile-Asp(OMe)-fluoromethyl ketone (Z-VEID-FMK). |
Z-VEID-FMK |
A1923-10 |
ApexBio |
10 mg |
EUR 756 |
Description: When compared to other caspase inhibitors, Z-DRHD-FMK inhibited caspase 6 activity more effectively than the general caspase inhibitor Z-Val-Ala-Asp (OMe)-fluoromethy ketone (Z-VAD-FMK) or the caspase 6 inhibitor Z-Val-Glu(Ome)-Ile-Asp(OMe)-fluoromethyl ketone (Z-VEID-FMK). |
Z-VEID-FMK |
A1923-25 |
ApexBio |
25 mg |
EUR 1173.6 |
Description: When compared to other caspase inhibitors, Z-DRHD-FMK inhibited caspase 6 activity more effectively than the general caspase inhibitor Z-Val-Ala-Asp (OMe)-fluoromethy ketone (Z-VAD-FMK) or the caspase 6 inhibitor Z-Val-Glu(Ome)-Ile-Asp(OMe)-fluoromethyl ketone (Z-VEID-FMK). |
Z-VEID-FMK |
A1923-5 |
ApexBio |
5 mg |
EUR 477.6 |
Description: When compared to other caspase inhibitors, Z-DRHD-FMK inhibited caspase 6 activity more effectively than the general caspase inhibitor Z-Val-Ala-Asp (OMe)-fluoromethy ketone (Z-VAD-FMK) or the caspase 6 inhibitor Z-Val-Glu(Ome)-Ile-Asp(OMe)-fluoromethyl ketone (Z-VEID-FMK). |
Z-VEID-FMK |
A1923-S |
ApexBio |
Evaluation Sample |
EUR 97.2 |
Description: When compared to other caspase inhibitors, Z-DRHD-FMK inhibited caspase 6 activity more effectively than the general caspase inhibitor Z-Val-Ala-Asp (OMe)-fluoromethy ketone (Z-VAD-FMK) or the caspase 6 inhibitor Z-Val-Glu(Ome)-Ile-Asp(OMe)-fluoromethyl ketone (Z-VEID-FMK). |
Z-WEHD-FMK |
A1924-1 |
ApexBio |
1 mg |
EUR 135.6 |
Description: Treatment of infected cells with pan-caspase inhibitor IV and Z-WEHD-FMK, an inhibitor of inflammatory caspases, elicited a near-complete blockage of C. trachomatis-induced cleavage of golgin-84. |
Z-WEHD-FMK |
A1924-10 |
ApexBio |
10 mg |
EUR 408 |
Description: Treatment of infected cells with pan-caspase inhibitor IV and Z-WEHD-FMK, an inhibitor of inflammatory caspases, elicited a near-complete blockage of C. trachomatis-induced cleavage of golgin-84. |
Z-WEHD-FMK |
A1924-25 |
ApexBio |
25 mg |
EUR 616.8 |
Description: Treatment of infected cells with pan-caspase inhibitor IV and Z-WEHD-FMK, an inhibitor of inflammatory caspases, elicited a near-complete blockage of C. trachomatis-induced cleavage of golgin-84. |
Z-WEHD-FMK |
A1924-5 |
ApexBio |
5 mg |
EUR 268.8 |
Description: Treatment of infected cells with pan-caspase inhibitor IV and Z-WEHD-FMK, an inhibitor of inflammatory caspases, elicited a near-complete blockage of C. trachomatis-induced cleavage of golgin-84. |
Z-IETD-FMK |
B3232-1 |
ApexBio |
1 mg |
EUR 393.6 |
Description: Z-IETD-FMK is an inhibitor of caspase 8 [1].Z-IETD-FMK inhibits T cell proliferation induced by PHA or anti-CD3 plus anti-CD28 without toxicity of resting T cells. |
Z-IETD-FMK |
B3232-5 |
ApexBio |
5 mg |
EUR 547.2 |
Description: Z-IETD-FMK is an inhibitor of caspase 8 [1].Z-IETD-FMK inhibits T cell proliferation induced by PHA or anti-CD3 plus anti-CD28 without toxicity of resting T cells. |
Z-IETD-FMK |
B3232-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 1201.2 |
Description: Z-IETD-FMK is an inhibitor of caspase 8 [1].Z-IETD-FMK inhibits T cell proliferation induced by PHA or anti-CD3 plus anti-CD28 without toxicity of resting T cells. |
Z-LEHD-FMK |
B3233-1 |
ApexBio |
1 mg |
EUR 420 |
Description: Z-LEHD-FMK is a specific and irreversible inhibitor of caspase-9 [1].Caspase-9 is an initiator caspase and plays an important role in the mitochondrial death pathway. |
Z-LEHD-FMK |
B3233-5 |
ApexBio |
5 mg |
EUR 1054.8 |
Description: Z-LEHD-FMK is a specific and irreversible inhibitor of caspase-9 [1].Caspase-9 is an initiator caspase and plays an important role in the mitochondrial death pathway. |
Calpain Inhibitor, Z-LLY-FMK |
B1506-1000 |
Biovision |
|
EUR 405.6 |
Calpain Inhibitor, Z-LLY-FMK |
B1506-250 |
Biovision |
|
EUR 261.6 |
Caspase-5 Inhibitor Z-WEHD-FMK |
1100-100 |
Biovision |
|
EUR 235.2 |
Caspase-5 Inhibitor Z-WEHD-FMK |
1100-20C |
Biovision |
|
EUR 235.2 |
Caspase-4 Inhibitor Z-LEVD-FMK |
1108-100 |
Biovision |
|
EUR 222 |
Caspase-4 Inhibitor Z-LEVD-FMK |
1108-20C |
Biovision |
|
EUR 222 |
EZSolution? Calpain Inhibitor, Z-LLY-FMK |
1125-20C |
Biovision |
|
EUR 222 |
EMAP-II Inhibitor Z-ASTD-FMK |
1127-20C |
Biovision |
|
EUR 314.4 |
Caspase-3 Inhibitor Z-DEVD-FMK |
1009-100 |
Biovision |
|
EUR 248.4 |
Caspase-3 Inhibitor Z-DEVD-FMK |
1009-20C |
Biovision |
|
EUR 248.4 |
Caspase-6 Inhibitor Z-VEID-FMK |
1011-100 |
Biovision |
|
EUR 222 |
Caspase-6 Inhibitor Z-VEID-FMK |
1011-20C |
Biovision |
|
EUR 222 |
Caspase-1 Inhibitor Z-YVAD-FMK |
1012-100 |
Biovision |
|
EUR 235.2 |
Caspase-1 Inhibitor Z-YVAD-FMK |
1012-20C |
Biovision |
|
EUR 235.2 |
Caspase-8 Inhibitor Z-IETD-FMK |
1064-100 |
Biovision |
|
EUR 235.2 |
Caspase-8 Inhibitor Z-IETD-FMK |
1064-20C |
Biovision |
|
EUR 235.2 |
Caspase-2 Inhibitor Z-VDVAD-FMK |
1073-100 |
Biovision |
|
EUR 222 |
Caspase-2 Inhibitor Z-VDVAD-FMK |
1073-20C |
Biovision |
|
EUR 222 |
Caspase-9 Inhibitor Z-LEHD-FMK |
1074-100 |
Biovision |
|
EUR 248.4 |
Caspase-9 Inhibitor Z-LEHD-FMK |
1074-20C |
Biovision |
|
EUR 248.4 |
Caspase-12 Inhibitor Z-ATAD-FMK |
1079-100 |
Biovision |
|
EUR 261.6 |
Caspase-12 Inhibitor Z-ATAD-FMK |
1079-20C |
Biovision |
|
EUR 261.6 |
Caspase-3 inhibitor, Z-DQMD-FMK |
2782-1 |
Biovision |
|
EUR 170.4 |
Caspase-3 inhibitor, Z-DQMD-FMK |
2782-5 |
Biovision |
|
EUR 496.8 |
Caspase-8 Inhibitor Z-IETD-FMK |
B4096-.02 |
ApexBio |
20 µl (10 mM) |
EUR 234 |
Description: Z-IETD-FMK is an inhibitor of caspase 8 [1].Z-IETD-FMK inhibits T cell proliferation induced by PHA or anti-CD3 plus anti-CD28 without toxicity of resting T cells. |
Caspase-8 Inhibitor Z-IETD-FMK |
B4096-.1 |
ApexBio |
100 µl (2 mM) |
EUR 234 |
Description: Z-IETD-FMK is an inhibitor of caspase 8 [1].Z-IETD-FMK inhibits T cell proliferation induced by PHA or anti-CD3 plus anti-CD28 without toxicity of resting T cells. |
Caspase-9 Inhibitor Z-LEHD-FMK |
B4573-.02 |
ApexBio |
20 µl (10 mM) |
EUR 234 |
Description: Z-LEHD-FMK is a specific and irreversible inhibitor of caspase-9 [1]. Caspase-9 is an initiator caspase and plays an important role in the mitochondrial death pathway. |
Caspase-9 Inhibitor Z-LEHD-FMK |
B4573-.1 |
ApexBio |
100 µl (2 mM) |
EUR 234 |
Description: Z-LEHD-FMK is a specific and irreversible inhibitor of caspase-9 [1]. Caspase-9 is an initiator caspase and plays an important role in the mitochondrial death pathway. |
Cathepsin B&L Inhibitor Z-Phe-Phe-FMK |
1126-20C |
Biovision |
|
EUR 274.8 |
FMK |
A3420-10 |
ApexBio |
10 mg |
EUR 447.6 |
Description: FMK is a potent, highly specific and irreversible ribosomal s6 kinase (RSK) inhibitor with IC50 value of 15 nM.[1]RSK is named for ribosomal protein s6, part of the translational machinery which are serine/threonine kinases and are activated by the MAPK/ERK pathway. |
Anti-DYKDDDDK Antibody | CFLG-45A-Z |
CFLG-45A-Z |
Immunology Consultants Laboratory |
0.1 mg |
EUR 348 |
Description: Anti-DYKDDDDK Antibody | CFLG-45A-Z | Immunology Consultants Laboratory Host: Chicken Format: Unconjugated AP Product Type: Primary Antibody Antibody Clonality: Polyclonal |
Anti-DYKDDDDK Antibody | CFLG-45F-Z |
CFLG-45F-Z |
Immunology Consultants Laboratory |
0.1 mg |
EUR 363 |
Description: Anti-DYKDDDDK Antibody | CFLG-45F-Z | Immunology Consultants Laboratory Host: Chicken Format: FITC Conjugated Product Type: Primary Antibody Antibody Clonality: Polyclonal |
Anti-DYKDDDDK Antibody | CFLG-45P-Z |
CFLG-45P-Z |
Immunology Consultants Laboratory |
0.1 mg |
EUR 379 |
Description: Anti-DYKDDDDK Antibody | CFLG-45P-Z | Immunology Consultants Laboratory Host: Chicken Format: HRP Conjugated Product Type: Primary Antibody Antibody Clonality: Polyclonal |
Anti-GFP Antibody | CGFP-45A-Z |
CGFP-45A-Z |
Immunology Consultants Laboratory |
0.1 mg |
EUR 308 |
Description: Anti-GFP Antibody | CGFP-45A-Z | Immunology Consultants Laboratory Host: Chicken Format: Unconjugated AP Product Type: Primary Antibody Antibody Clonality: Polyclonal |
Anti-HA Antibody | CHGT-45A-Z |
CHGT-45A-Z |
Immunology Consultants Laboratory |
0.1 mg |
EUR 348 |
Description: Anti-HA Antibody | CHGT-45A-Z | Immunology Consultants Laboratory Host: Chicken Format: Unconjugated AP Product Type: Primary Antibody Antibody Clonality: Polyclonal |
Z-VAD-FMK